PREDICTORS OF SPONTANEOUS CEREBRAL AVM HEMORRHAGE
自发性脑动静脉畸形出血的预测因素
基本信息
- 批准号:2519984
- 负责人:
- 金额:$ 15.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-30 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Abstract) AVMs represent a small proportion
of the total incidence of stroke but typically affect otherwise healthy
young adults, usually in the productive years of life. The primary
reason to treat cerebral arteriovenous malformations (AVMs) is the
prophylaxis against new or recurrent intracranial hemorrhage (ICH).
However, treatment of AVMs by surgery, endovascualar embolization and
radiosurgery carries a significant risk. Further, since ICH prevention
is the main impetus to treat AVMs, treatment risk for complex lesions
should be less than the projected cumulative risk for spontaneous ICH.
In our preliminary work we have strong evidence that certain
angiographic and physiologic factors are related to an initial
presentation of ICH. Further, in a prospective preliminary study, we
have shown that initial presentation of with ICH is related to recurrent
hemorrhage, which supports the notion that factors associated with the
presenting ICH should be predictive of recurrent ICH. The general
objectives of this study are 1) to complete a prospective observational
study of recurrent spontaneous AVM hemorrhage; 2) to explicitly define
the clinical, morphologic, and hemodynamic criteria that are associated
with the initial presentation of ICH; and 3) to identify a reliable set
of risk factors to predict ICH.
We hypothesize that there exists a set of distinct physiologic and
anatomic conditions that increase the risk for spontaneous ICH.
Further, we hypothesize that a number of factors are associated with a
low incidence of ICH, including a) large AVM size, b) low intranidal
pressure, c) lack of periventricular deep venous drainage and venous
stenosis and d) lack of dysfunctional dilation, i.e., aneurysm
formation. Because, paradoxically, such patients at low risk from the
natural history of the disease may often by at the highest treatment
(surgical) risk, this group needs to be identified for optimal outcome
management.
Therefore, we propose studies on 120 AVM patients over a three-year
period. Using an established databank, we will collect data from
clinical course, standard imaging (angiography, CT, MRI), and
physiologic (intravascular pressure) characteristics. We will develop
a statistical model, based on explicit anatomic and physiologic
criteria, for prediction of spontaneous ICH that can be weighed against
treatment risk. We will also be able to add the proposed 120 new
patients to our existing prospective sample (n=150) to complete the
observational study of new or recurrent spontaneous AVM hemorrhage.
At the conclusion of the grant period, our goal is to be in a position
to construct and justify rational clinical trials that will randomize
patients with high treatment risk and what we will determine to be low
natural history risk into conservative versus aggressive therapy groups,
including some combination of non-interventional, endovascular,
radiosurgical or surgical treatment. The project will lead to a better
understanding of the pathophysiology and natural history of cerebral AVMs
and a more cost-effective use of medical resources by allowing more
rational selection of patients for complex and multi-modal treatment.
描述:(申请人摘要)AVM占一小部分
但通常影响其他健康的人
年轻的成年人,通常是在生命的生产年。主
治疗脑动静脉畸形(AVM)的原因是
预防新发或复发性颅内出血(ICH)。
然而,通过手术、血管内栓塞和
放射外科手术具有很大的风险。此外,由于ICH预防
是治疗AVM的主要动力,复杂病变的治疗风险
应低于自发性ICH的预计累积风险。
在我们的初步工作中,我们有强有力的证据表明,
血管造影和生理因素与初始
介绍ICH。此外,在一项前瞻性的初步研究中,我们
已经表明,ICH的初始表现与复发有关,
出血,这支持了这样的观点,即与出血相关的因素,
出现ICH应是复发性ICH的预测因素。总
本研究的目的是1)完成前瞻性观察
复发性自发性AVM出血研究; 2)明确定义
相关的临床、形态学和血流动力学标准
与ICH的初始表现;和3)确定可靠的集合
预测ICH的危险因素。
我们假设存在一组不同的生理和
增加自发性ICH风险的解剖条件。
此外,我们假设,一些因素与一个
ICH发生率低,包括a)AVM尺寸大,B)脑内出血率低
压力,c)缺乏脑室周围深静脉引流和静脉
狭窄和d)缺乏功能失调性扩张,即,动脉瘤
阵因为,矛盾的是,这些患者的风险较低,
疾病的自然史可能经常在最高治疗
(手术)风险,需要识别该组以获得最佳结局
管理
因此,我们建议对120例AVM患者进行为期三年的研究
期使用已建立的数据库,我们将收集数据,
临床病程、标准成像(血管造影、CT、MRI),以及
生理(血管内压力)特征。我们将开发
一个统计模型,基于明确的解剖和生理
标准,用于预测自发性ICH,可与
治疗风险。我们还将能够增加拟议的120个新的
患者与我们现有的前瞻性样本(n=150),以完成
新发或复发性自发性AVM出血的观察性研究。
在资助期结束时,我们的目标是
构建和证明合理的临床试验,
治疗风险高的患者以及我们确定为低风险的患者
自然病史风险分为保守治疗组和积极治疗组,
包括非介入性,血管内,
放射外科或外科治疗。该项目将导致更好的
了解脑AVM的病理生理学和自然史
以及更有效地利用医疗资源,
合理选择患者进行复杂和多模式治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM L YOUNG其他文献
WILLIAM L YOUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM L YOUNG', 18)}}的其他基金
Brain Vascular Malformation Consortium: Predictors of clinical course
脑血管畸形联盟:临床病程的预测因子
- 批准号:
8325092 - 财政年份:2009
- 资助金额:
$ 15.54万 - 项目类别:
Brain Vascular Malformation Consortium: Predictors of clinical course
脑血管畸形联盟:临床病程的预测因子
- 批准号:
7943115 - 财政年份:2009
- 资助金额:
$ 15.54万 - 项目类别:
Brain Vascular Malformation Consortium: Predictors of clinical course
脑血管畸形联盟:临床病程的预测因子
- 批准号:
8137700 - 财政年份:2009
- 资助金额:
$ 15.54万 - 项目类别:
Brain Vascular Malformation Consortium: Predictors of clinical course
脑血管畸形联盟:临床病程的预测因子
- 批准号:
7681370 - 财政年份:2009
- 资助金额:
$ 15.54万 - 项目类别:
Brain Vascular Malformation Consortium: Predictors of clinical course
脑血管畸形联盟:临床病程的预测因子
- 批准号:
8113515 - 财政年份:2009
- 资助金额:
$ 15.54万 - 项目类别:
TETRACYCLINE-DERIVATIVES FOR TREATMENT OF CEREBRAL ARTERIOVENOUS MALFORMATINS AN
用于治疗脑动静脉畸形的四环素衍生物
- 批准号:
7202653 - 财政年份:2005
- 资助金额:
$ 15.54万 - 项目类别:
Interaction Of ApoE Genotype On Outcome In Patients With Strokes & Brain Injury
ApoE 基因型与中风患者预后的相互作用
- 批准号:
6972281 - 财政年份:2004
- 资助金额:
$ 15.54万 - 项目类别:
相似海外基金
Role of mechanical heterogeneity in cerebral aneurysm growth and rupture
机械异质性在脑动脉瘤生长和破裂中的作用
- 批准号:
10585539 - 财政年份:2023
- 资助金额:
$ 15.54万 - 项目类别:
Study on development of prophylaxis for recanalization after coil embolization of cerebral aneurysm and elucidation of its mechanisms
脑动脉瘤弹簧圈栓塞术后再通预防措施的研究进展及机制阐明
- 批准号:
23K08512 - 财政年份:2023
- 资助金额:
$ 15.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of wall elasticity on hemodynamics inside patient-specific cerebral aneurysm
壁弹性对患者特异性脑动脉瘤内血流动力学的影响
- 批准号:
22K03919 - 财政年份:2022
- 资助金额:
$ 15.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel MRI contrast agents for macrophage imaging enables risk evaluation of unruptured cerebral aneurysm
开发用于巨噬细胞成像的新型 MRI 造影剂可以评估未破裂脑动脉瘤的风险
- 批准号:
22K05356 - 财政年份:2022
- 资助金额:
$ 15.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation for the molecular biological role of myoglobin in the cerebral aneurysm walls
脑动脉瘤壁中肌红蛋白分子生物学作用的研究
- 批准号:
22K09232 - 财政年份:2022
- 资助金额:
$ 15.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Endothelial cell dysfunction in cerebral aneurysm pathogenesis
脑动脉瘤发病机制中的内皮细胞功能障碍
- 批准号:
10529287 - 财政年份:2021
- 资助金额:
$ 15.54万 - 项目类别:
Endothelial cell dysfunction in cerebral aneurysm pathogenesis
脑动脉瘤发病机制中的内皮细胞功能障碍
- 批准号:
10308020 - 财政年份:2021
- 资助金额:
$ 15.54万 - 项目类别:
Non-invasive Detection of Cerebral Aneurysm Recurrence after Endovascular Treatment Using Automated Image Processing
使用自动图像处理无创检测血管内治疗后脑动脉瘤复发
- 批准号:
9907673 - 财政年份:2020
- 资助金额:
$ 15.54万 - 项目类别:
Inflammatory Mediators and Mechanisms of Cerebral Aneurysm Formation and Rupture
脑动脉瘤形成和破裂的炎症介质和机制
- 批准号:
10393517 - 财政年份:2020
- 资助金额:
$ 15.54万 - 项目类别:
Inflammatory Mediators and Mechanisms of Cerebral Aneurysm Formation and Rupture
脑动脉瘤形成和破裂的炎症介质和机制
- 批准号:
9887928 - 财政年份:2020
- 资助金额:
$ 15.54万 - 项目类别:














{{item.name}}会员




